| BCBS Louisiana | Peripheral Nerve Injury Repair Using Synthetic Conduits or Processed Nerve Allografts | 2026-06-01 |
| BCBS Louisiana | crinecerfont (Crenessity™) | 2026-06-01 |
| BCBS Louisiana | Vanzacaftor/tezacaftor/deutivacaftor (Alyftrek™) | 2026-06-01 |
| BCBS Louisiana | acoramidis (Attruby™) | 2026-06-01 |
| Ambetter Health Florida Clinical | Transcranial Magnetic Stimulation for Treatment Resistant Major Depression | 2026-06-01 |
| UHC Surest Medical and Drug | Hemgenix® (Etranacogene Dezaparvovec-Drlb) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Intravenous Enzyme Replacement Therapy (ERT) for Gaucher Disease – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Orencia® (Abatacept) Injection for Intravenous Infusion – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-06-01 |
| UHC Surest Medical and Drug | Oxlumo® (Lumasiran) and Rivfloza® (Nedosiran) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-06-01 |
| UHC Surest Medical and Drug | RNA-Targeted Therapies (Amvuttra® and Onpattro®) – Commercial and Individual Exchange Medical Benefit Drug Policy | 2026-06-01 |